Global Covid-19 Therapeutic Market Growth (Status and Outlook) 2023-2029

March 2023 | 92 pages | ID: G40A78DE7E2CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global Covid-19 Therapeutic market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of Covid-19 Therapeutic market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Immunotherapy
• Life Support
• Antiviral Medicine
• Plasma Therapy
• Others

Segmentation by Application:

• Children
• Adult

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Cadila Healthcare
• Johnson & Johnson
• ImmunoPrecise
• Novartis
• AstraZeneca
• Cipla
• AbbVie
• Bayer
• Regeneron Pharmaceuticals
• Ascletis Pharma
• GlaxoSmithKline
• Gilead Sciences
• Pharmstandard
• Fujifilm Holdings
• Zhejiang Hisun Pharmaceutical Co. Ltd
• Roche
• Sanofi
• Pfizer

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Covid-19 Therapeutic Market Size 2024-2029
  2.1.2 Covid-19 Therapeutic Market Size CAGR by Region
2.2 Covid-19 Therapeutic Segment by Type
  2.2.1 Immunotherapy
  2.2.2 Life Support
  2.2.3 Antiviral Medicine
  2.2.4 Plasma Therapy
  2.2.5 Others
2.3 Covid-19 Therapeutic Market Size by Type
  2.3.1 Global Covid-19 Therapeutic Market Size Market Share by Type (2024-2029)
  2.3.2 Global Covid-19 Therapeutic Market Size Growth Rate by Type (2024-2029)
2.4 Covid-19 Therapeutic Segment by Application
  2.4.1 Children
  2.4.2 Adult
2.5 Covid-19 Therapeutic Market Size by Application
  2.5.1 Global Covid-19 Therapeutic Market Size Market Share by Application (2024-2029)
  2.5.2 Global Covid-19 Therapeutic Market Size Growth Rate by Application (2024-2029)

3 COVID-19 THERAPEUTIC KEY PLAYERS

3.1 Date of Key Players Enter into Covid-19 Therapeutic
3.2 Key Players Covid-19 Therapeutic Product Offered
3.3 Key Players Covid-19 Therapeutic Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Covid-19 Therapeutic Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 COVID-19 THERAPEUTIC BY REGIONS

4.1 Covid-19 Therapeutic Market Size by Regions (2024-2029)
4.2 United States Covid-19 Therapeutic Market Size Growth (2024-2029)
4.3 China Covid-19 Therapeutic Market Size Growth (2024-2029)
4.4 Europe Covid-19 Therapeutic Market Size Growth (2024-2029)
4.5 Rest of World Covid-19 Therapeutic Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States Covid-19 Therapeutic Market Size by Type (2024-2029)
5.2 United States Covid-19 Therapeutic Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe Covid-19 Therapeutic Market Size by Type (2024-2029)
6.2 Europe Covid-19 Therapeutic Market Size by Application (2024-2029)

7 CHINA

7.1 China Covid-19 Therapeutic Market Size by Type (2024-2029)
7.2 China Covid-19 Therapeutic Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World Covid-19 Therapeutic Market Size by Type (2024-2029)
8.2 Rest of World Covid-19 Therapeutic Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN COVID-19 THERAPEUTIC

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Cadila Healthcare
  11.1.1 Cadila Healthcare Company Details
  11.1.2 Cadila Healthcare Covid-19 Therapeutic Product Offered
  11.1.3 Cadila Healthcare Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.1.4 Cadila Healthcare Main Business Overview
  11.1.5 Cadila Healthcare News
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Details
  11.2.2 Johnson & Johnson Covid-19 Therapeutic Product Offered
  11.2.3 Johnson & Johnson Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson News
11.3 ImmunoPrecise
  11.3.1 ImmunoPrecise Company Details
  11.3.2 ImmunoPrecise Covid-19 Therapeutic Product Offered
  11.3.3 ImmunoPrecise Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.3.4 ImmunoPrecise Main Business Overview
  11.3.5 ImmunoPrecise News
11.4 Novartis
  11.4.1 Novartis Company Details
  11.4.2 Novartis Covid-19 Therapeutic Product Offered
  11.4.3 Novartis Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis News
11.5 AstraZeneca
  11.5.1 AstraZeneca Company Details
  11.5.2 AstraZeneca Covid-19 Therapeutic Product Offered
  11.5.3 AstraZeneca Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.5.4 AstraZeneca Main Business Overview
  11.5.5 AstraZeneca News
11.6 Cipla
  11.6.1 Cipla Company Details
  11.6.2 Cipla Covid-19 Therapeutic Product Offered
  11.6.3 Cipla Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.6.4 Cipla Main Business Overview
  11.6.5 Cipla News
11.7 AbbVie
  11.7.1 AbbVie Company Details
  11.7.2 AbbVie Covid-19 Therapeutic Product Offered
  11.7.3 AbbVie Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.7.4 AbbVie Main Business Overview
  11.7.5 AbbVie News
11.8 Bayer
  11.8.1 Bayer Company Details
  11.8.2 Bayer Covid-19 Therapeutic Product Offered
  11.8.3 Bayer Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.8.4 Bayer Main Business Overview
  11.8.5 Bayer News
11.9 Regeneron Pharmaceuticals
  11.9.1 Regeneron Pharmaceuticals Company Details
  11.9.2 Regeneron Pharmaceuticals Covid-19 Therapeutic Product Offered
  11.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.9.4 Regeneron Pharmaceuticals Main Business Overview
  11.9.5 Regeneron Pharmaceuticals News
11.10 Ascletis Pharma
  11.10.1 Ascletis Pharma Company Details
  11.10.2 Ascletis Pharma Covid-19 Therapeutic Product Offered
  11.10.3 Ascletis Pharma Covid-19 Therapeutic Market Size (2023 VS 2029)
  11.10.4 Ascletis Pharma Main Business Overview
  11.10.5 Ascletis Pharma News
11.11 GlaxoSmithKline
11.12 Gilead Sciences
11.13 Pharmstandard
11.14 Fujifilm Holdings
11.15 Zhejiang Hisun Pharmaceutical Co. Ltd
11.16 Roche
11.17 Sanofi
11.18 Pfizer

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Covid-19 Therapeutic Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Immunotherapy
Table 3. Major Players of Life Support
Table 4. Major Players of Antiviral Medicine
Table 5. Major Players of Plasma Therapy
Table 6. Major Players of Others
Table 7. Global Covid-19 Therapeutic Market Size by Type (2024-2029) ($ Millions)
Table 8. Global Covid-19 Therapeutic Market Size Market Share by Type (2024-2029)
Table 9. Global Covid-19 Therapeutic Market Size by Application (2024-2029) ($ Millions)
Table 10. Global Covid-19 Therapeutic Market Size Market Share by Application (2024-2029)
Table 11. Date of Global Key Players Enter into Covid-19 Therapeutic Market
Table 12. Global Key Players Covid-19 Therapeutic Product Offered
Table 13. Key Players Covid-19 Therapeutic Funding/Investment ($ Millions)
Table 14. Funding/Investment by Regions
Table 15. Funding/Investment by End Industry
Table 16. Key Players Covid-19 Therapeutic Valuation & Market Capitalization ($ Millions)
Table 17. Key Players Mergers & Acquisitions, Expansion Plans
Table 18. Covid-19 Therapeutic New Product/Technology Launches
Table 19. Covid-19 Therapeutic Industry Partnerships, Agreements, and Collaborations
Table 20. Covid-19 Therapeutic Industry Mergers and Acquisitions
Table 21. Global Covid-19 Therapeutic Market Size by Regions 2024-2029 ($ Millions)
Table 22. Global Covid-19 Therapeutic Market Size Market Share by Regions 2024-2029
Table 23. United States Covid-19 Therapeutic Market Size by Type (2024-2029) ($ Millions)
Table 24. United States Covid-19 Therapeutic Market Size Market Share by Type (2024-2029)
Table 25. United States Covid-19 Therapeutic Market Size by Application (2024-2029) ($ Millions)
Table 26. United States Covid-19 Therapeutic Market Size Market Share by Application (2024-2029)
Table 27. Europe Covid-19 Therapeutic Market Size by Type (2024-2029) ($ Millions)
Table 28. Europe Covid-19 Therapeutic Market Size Market Share by Type (2024-2029)
Table 29. Europe Covid-19 Therapeutic Market Size by Application (2024-2029) ($ Millions)
Table 30. Europe Covid-19 Therapeutic Market Size Market Share by Application (2024-2029)
Table 31. China Covid-19 Therapeutic Market Size by Type (2024-2029) ($ Millions)
Table 32. China Covid-19 Therapeutic Market Size Market Share by Type (2024-2029)
Table 33. China Covid-19 Therapeutic Market Size by Application (2024-2029) ($ Millions)
Table 34. China Covid-19 Therapeutic Market Size Market Share by Application (2024-2029)
Table 35. Rest of World Covid-19 Therapeutic Market Size by Type (2024-2029) ($ Millions)
Table 36. Rest of World Covid-19 Therapeutic Market Size Market Share by Type (2024-2029)
Table 37. Rest of World Covid-19 Therapeutic Market Size by Application (2024-2029) ($ Millions)
Table 38. Rest of World Covid-19 Therapeutic Market Size Market Share by Application (2024-2029)
Table 39. Key Market Drivers & Growth Opportunities of Covid-19 Therapeutic
Table 40. Key Market Challenges & Risks of Covid-19 Therapeutic
Table 41. Key Industry Trends of Covid-19 Therapeutic
Table 42. Company A Company Details
Table 43. Companies Invested by Company A
Table 44. Company A Key Development and Market Layout
Table 45. Company B Company Details
Table 46. Companies Invested by Company B
Table 47. Company B Key Development and Market Layout
Table 48. Company C Company Details
Table 49. Companies Invested by Company C
Table 50. Company C Key Development and Market Layout
Table 51. Company C Company Details
Table 52. Companies Invested by Company C
Table 53. Company C Key Development and Market Layout
Table 54. Cadila Healthcare Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Cadila Healthcare Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 56. Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Johnson & Johnson Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 58. ImmunoPrecise Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. ImmunoPrecise Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 60. Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Novartis Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 62. AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. AstraZeneca Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 64. Cipla Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Cipla Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 66. AbbVie Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. AbbVie Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 68. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Bayer Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 70. Regeneron Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Regeneron Pharmaceuticals Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 72. Ascletis Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Ascletis Pharma Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 74. GlaxoSmithKline Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. GlaxoSmithKline Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 76. Gilead Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Gilead Sciences Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 78. Pharmstandard Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. Pharmstandard Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 80. Fujifilm Holdings Basic Information, Head Office, Major Market Areas and Its Competitors
Table 81. Fujifilm Holdings Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 82. Zhejiang Hisun Pharmaceutical Co. Ltd Basic Information, Head Office, Major Market Areas and Its Competitors
Table 83. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 84. Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table 85. Roche Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 86. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table 87. Sanofi Covid-19 Therapeutic Market Size (2023 VS 2029)
Table 88. Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 89. Pfizer Covid-19 Therapeutic Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Covid-19 Therapeutic
Figure 2. Covid-19 Therapeutic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Covid-19 Therapeutic Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. Covid-19 Therapeutic Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global Covid-19 Therapeutic Market Size Market Share by Type (2024-2029)
Figure 9. Global Immunotherapy Market Size Growth Rate
Figure 10. Global Life Support Market Size Growth Rate
Figure 11. Global Antiviral Medicine Market Size Growth Rate
Figure 12. Global Plasma Therapy Market Size Growth Rate
Figure 13. Global Others Market Size Growth Rate
Figure 14. Covid-19 Therapeutic in Children
Figure 15. Global Covid-19 Therapeutic Market: Children (2024-2029) ($ Millions)
Figure 16. Covid-19 Therapeutic in Adult
Figure 17. Global Covid-19 Therapeutic Market: Adult (2024-2029) ($ Millions)
Figure 18. Global Covid-19 Therapeutic Market Size Market Share by Application (2024-2029)
Figure 19. Global Covid-19 Therapeutic Market Size in Children Growth Rate
Figure 20. Global Covid-19 Therapeutic Market Size in Adult Growth Rate
Figure 21. Funding/Investment
Figure 22. Global Covid-19 Therapeutic Market Size Market Share by Regions 2024-2029
Figure 23. United States Covid-19 Therapeutic Market Size 2024-2029 ($ Millions)
Figure 24. China Covid-19 Therapeutic Market Size 2024-2029 ($ Millions)
Figure 25. Europe Covid-19 Therapeutic Market Size 2024-2029 ($ Millions)
Figure 26. Rest of World Covid-19 Therapeutic Market Size 2024-2029 ($ Millions)
Figure 27. United States Covid-19 Therapeutic Consumption Market Share by Type in 2029
Figure 28. United States Covid-19 Therapeutic Market Size Market Share by Application in 2029
Figure 29. China Covid-19 Therapeutic Consumption Market Share by Type in 2029
Figure 30. China Covid-19 Therapeutic Market Size Market Share by Application in 2029
Figure 31. Europe Covid-19 Therapeutic Consumption Market Share by Type in 2029
Figure 32. Europe Covid-19 Therapeutic Market Size Market Share by Application in 2029
Figure 33. Rest of World Covid-19 Therapeutic Consumption Market Share by Type in 2029
Figure 34. Rest of World Covid-19 Therapeutic Market Size Market Share by Application in 2029